Our researchers

Among the researchers at the Cancer Center are three groups: basic scientists, translational researchers and clinical researchers. The basic scientists compare normal and abnormal cells, identifying and validating targets for drug intervention in vitro and in animal models. Translational researchers look for new investigational drugs and design human trials. The clinical researchers conduct Phase I, II and III trials with patients. These scientists and physician scientists work collaboratively.

      A - E                               F - J                               K - O                               P - T                               U - Z

 

 

 A - E

Elena Astapova Wood, MD, PhD

Associate Director of the Center for Telehealth

 

 

 

 

 

Farrukh T. Awan, MD

Cancer Immunology and Immunotherapy

 

 

 

 

 

E. Gerald Bennett, PhD

Cancer Prevention & Control

 

 

 

 

Paul Biddinger, MD

Developmental Therapeutics, Head and Neck Cancer Multidisciplinary Taskforce, Thoracic Oncology Research Group, Pathologist

 

 

 

 

 

Erhard Bieberich, PhD

Molecular Oncology Program, Molecular Signaling; Institute of Molecular Medicine and Genetics

 

 

 

Wendy Bollag, PhD

Molecular Oncology Program, Molecular Signaling

 

 

 

 

 

Jimmy J. Brown, MD

Developmental Therapeutics

 

 

 

 

Darren Browning, PhD

Molecular Oncology Program, Molecular Signaling

 

 

 

 

 

 

Phillip Joe Buckhaults, PhD

Molecular Oncology Program, Genomics / Epigenomics

 

 

 

Anil G. Cashikar, PhD

Center for Molecular Chaperone / Radiobiology and Cancer Virology;
Molecular Oncology Program, Chaperone Biology

 

 

 

 

 

Ahmed Chadli, PhD

Center for Molecular Chaperone / Radiobiology and Cancer Virology;
Molecular Oncology Program, Chaperone Biology

 

 

 

 

 

Phillip Chandler, PhD

Cancer Immunology and Immunotherapy

 

 

 

 

 

 

 Jeonghyeon (Justin) Choi, PhD

  Molecular Oncology Program, Genomics / Epigenomics

 
  
  

 

 

Teresa Coleman, MD

Multidisciplinary Genitourinary / Prostate Cancer Team, Medical Oncologist

 

 

 

 

 

 

John Cowell, PhD, DSc, FRCPath

Associate Center Director for Basic Science; Molecular Oncology Program, Molecular Signaling, Leader; Genomics / Epigenomics; Genetics Researcher

 

 

 

 

 

Paul Dainer, MD

Cancer Prevention & Control

 

 

 

 

Han-Fei Ding, PhD

Molecular Oncology Program, Molecular Signaling

 

 

 

 

 

 

Quansheng Du, PhD, DSc

Developmental Therapeutics

 

 

 

 

 

 

William Dynan, PhD

Molecular Oncology Program; Developmental Therpeutics

 

 

 

 

 

 

Ali Eroglu, PhD, DVM

Molecular Oncology Program

 

 

 

 

 

 

 

 

[Back to Top]